iBio, Inc.
IBIO
$4.65
-$0.21-4.32%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 375.00K | 175.00K | 225.00K | 50.00K | 50.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 375.00K | 175.00K | 225.00K | 50.00K | 50.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 375.00K | 175.00K | 225.00K | 50.00K | 50.00K |
| SG&A Expenses | 10.71M | 10.93M | 11.67M | 11.84M | 12.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.94M | 15.81M | 16.86M | 18.24M | 20.78M |
| Operating Income | -15.56M | -15.64M | -16.63M | -18.19M | -20.73M |
| Income Before Tax | -14.23M | -14.36M | -15.44M | -17.13M | -20.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -14.23 | -14.36 | -15.44 | -17.13 | -20.77 |
| Earnings from Discontinued Operations | -5.07M | -8.79M | -9.46M | -6.03M | -6.51M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.30M | -23.15M | -24.91M | -23.16M | -27.28M |
| EBIT | -15.56M | -15.64M | -16.63M | -18.19M | -20.73M |
| EBITDA | -14.71M | -14.75M | -15.71M | -17.25M | -19.83M |
| EPS Basic | -2.70 | -6.65 | -10.98 | -17.11 | -27.32 |
| Normalized Basic EPS | -1.44 | -2.65 | -5.01 | -8.36 | -13.61 |
| EPS Diluted | -2.70 | -6.65 | -10.98 | -17.11 | -27.32 |
| Normalized Diluted EPS | -1.44 | -2.65 | -5.01 | -8.36 | -13.61 |
| Average Basic Shares Outstanding | 30.06M | 22.79M | 15.35M | 7.63M | 4.57M |
| Average Diluted Shares Outstanding | 30.06M | 22.79M | 15.35M | 7.63M | 4.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
